Effect of the addition of temsirolimus to cetuximab in cetuximab-resistant head and neck cancers: Results of the randomized PII MAESTRO study.-Reference-Cited by-同舟云学术

Effect of the addition of temsirolimus to cetuximab in cetuximab-resistant head and neck cancers: Results of the randomized PII MAESTRO study.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:6089-6089
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Chawla Apoorva¹,Adkins Douglas²,Worden Francis P.³,Rao Krishna A.⁴,Hu H. Shawn⁵,Price Katharine Andress Rowe⁶,Zavala Jose D¹,Karrison Theodore¹,Stadler Walter Michael¹,Villaflor Victoria Meucci¹,Lussier Yves A.⁷,Vokes Everett E.¹,Cohen Ezra E.W.⁸,Seiwert Tanguy Y.¹

Affiliation:

1. The University of Chicago Medicine and Biological Sciences, Chicago, IL

2. Washington University School of Medicine in St. Louis, St. Louis, MO

3. University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

4. Southern Illinois University School of Medicine, Springfield, IL

5. St. John's Mercy Medical Center, St. Louis, MO

6. Mayo Clinic, Rochester, MN

7. University of Illinois Hospital and Health Sciences System, Chicago, IL

8. University of California, San Diego, San Diego, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject